Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke

Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways

(2015) Federico Carbone et al.   VASCULAR PHARMACOLOGY

Statin Treatment Is Associated with Reduction in Serum Levels of Receptor Activator of NF-κB Ligand and Neutrophil Activation in Patients with Severe Carotid Stenosis

(2014) Sébastien Lenglet et al.   MEDIATORS OF INFLAMMATION

The Role of Serum Osteoprotegerin and S-100 Protein Levels in Patients with Acute Ischaemic Stroke: Determination of Stroke Subtype, Severity and Mortality

(2013) M Üstündağ et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis

(2013) Constantinos Giaginis et al.   MEDICAL SCIENCE MONITOR

An Updated Definition of Stroke for the 21st Century

(2013) Ralph L. Sacco et al.   STROKE

High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention

(2013) Mette Bjerre et al.   European Journal of Preventive Cardiology

Osteopontin Upregulation in Atherogenesis Is Associated with Cellular Oxidative Stress Triggered by the Activation of Scavenger Receptors

(2012) Azucena E. Jiménez-Corona et al.   ARCHIVES OF MEDICAL RESEARCH

Association of plasma osteoprotegerin levels with stroke severity and functional outcome in acute ischaemic stroke patients

(2012) Tae-Jin Song et al.   BIOMARKERS

In vitro and clinical studies examining the expression of osteopontin in cigarette smoke-exposed endothelial cells and cigarette smokers

(2012) Emma Bishop et al.   BMC Cardiovascular Disorders

The osteoclast, bone remodelling and treatment of metabolic bone disease

(2012) Brendan F. Boyce et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Osteoprotegerin as a marker of atherosclerosis: A systematic update

(2012) Susanne Elisabeth Hosbond et al.   SCANDINAVIAN CARDIOVASCULAR JOURNAL

Osteopontin and Wound Healing in Bone

(2011) Marc D. McKee et al.   CELLS TISSUES ORGANS

Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI

(2011) Annamaria Mazzone et al.   CORONARY ARTERY DISEASE

Osteopontin Reduced Hypoxia–Ischemia Neonatal Brain Injury by Suppression of Apoptosis in a Rat Pup Model

(2011) Wanqiu Chen et al.   STROKE

Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis

(2010) Yukihiko Momiyama et al.   ATHEROSCLEROSIS

Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling

(2010) Alessandra Quercioli et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Oxidized low-density lipoprotein increases osteopontin expression by generation of oxidative stress

(2010) Cécile Mazière et al.   FREE RADICAL BIOLOGY AND MEDICINE

Osteopontin: Correlation with phagocytosis by brain macrophages in a rat model of stroke

(2010) Yoo-Jin Shin et al.   GLIA

Osteopontin predicts long-term functional outcome among ischemic stroke patients

(2010) M. Mendioroz et al.   JOURNAL OF NEUROLOGY

Relation between serum osteoprotegerin and carotid intima media thickness in a general population - the Tromsø Study

(2010) A. VIK et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Osteopontin: A multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification

(2009) Hyun-Ju Cho et al.   Current Atherosclerosis Reports

Osteoprotegerin concentrations and prognosis in acute ischaemic stroke

(2009) J. K. Jensen et al.   JOURNAL OF INTERNAL MEDICINE

The role of osteopontin in inflammatory processes

(2009) Susan Amanda Lund et al.   Journal of Cell Communication and Signaling

The expression of osteopontin is increased in vessels with blood–brain barrier impairment

(2007) Y. Iwanaga et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY